News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

IMRIS to Hold First Quarter 2013 Results Conference Call and 2013 Annual Meeting of Shareholders


5/1/2013 6:09:38 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

WINNIPEG, April 30, 2013 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM)

First Quarter 2013 Earnings ReleaseMay 2, 2013
Conference Call and WebcastMay 2, 2013 5:00 pm ET
Hosted by David Graves, Chairman and Chief Executive Officer;
Kelly McNeill, Executive Vice President, Finance & CFO
Participant Numbers 416-644-3416 or 1-800-814-4860
Conference Call ID Number 4615854

A question and answer session for analysts and institutional investors will follow management's presentation. A taped rebroadcast will be available to listeners until 12 a.m. on May 9, 2013. To access the rebroadcast, please dial 416-640-1917 or 1-877-289-8525 and enter the passcode 4615854#.

Annual General MeetingMay 2, 2013 6:00 pm ET
Hosted by David Graves, Chairman and Chief Executive Officer;
Kelly McNeill, Executive Vice President, Finance & CFO
Location Bedford Room
PARK HYATT TORONTO
4 Avenue Road
Toronto, Ontario

Following the formal part of the meeting, management will host a question and answer session. A live audio webcast of the meeting will be available on the company's website at www.imris.com.

About IMRIS

IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image guided therapy solutions through its VISIUS Surgical Theatre - a revolutionary, multifunctional surgical environment that provides unmatched intraoperative vision to clinicians to assist in decision making and enhance precision in treatment. VISIUS Surgical Theatres serve the neurosurgical, cardiovascular and cerebrovascular markets and have been selected by leading medical institutions around the world.

SOURCE IMRIS Inc.

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

comments powered by Disqus
IMRIS
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES